Seizures clinical trials at UCSD

2 in progress, 1 open to eligible people

Showing trials for

  • Levetiracetam in the Treatment of Neonatal Seizures

    open to eligible people ages up to 1 month

    The main purpose of this study is to determine the maximum safe tolerated dose of LEV in the treatment of neonatal seizures. Our hypothesis is that optimal dosing of Levetiracetam (LEV) to treat neonatal seizures is significantly greater than…

    San Diego, California and other locations

  • Cenobamate Open-Label Extension Study for YKP3089C025

    Sorry, accepting new patients by invitation only

    52 Week Open-Label Safety Study of Cenobamate for Subjects who Complete YKP3089C025 (core study)

    La Jolla, California and other locations

Our lead scientists for Seizures research studies include .